 |
|
Stem cells provide clues to cancer spread
May 23, 2007Scientists have made a breakthrough in understanding how cancers spread in what could lead to new ways of beating the disease.
The University of Manchester study used embryonic stem (ES) cells to investigate how some tumours are able to migrate to other parts of the body, which makes the treatment of cancer much more difficult.
Dr Chris Ward, in the University's Faculty of Medical and Human Sciences, studied a crucial change that makes cancer cells able to start moving and spread into other tissues.
Normal cells, as well as early cancer cells, are called epithelial cells because they bind tightly to each other forming stable layers of tissue. However, as a tumour becomes more advanced, some of the cells change to become 'mesenchymal'.
Mesenchymal cells do not bind to each other, forming more disorganised tissues in which the cells can move around. Since this crucial change - known as the epithelial-mesenchymal transition, was first observed in the early embryo, Dr Ward theorised that embryonic stem cells might undergo a similar process.
Dr Ward, whose findings are published in the journal Molecular Biology of the Cell, said: "We have shown that ES cells spontaneously change in a manner that is remarkably similar to the epithelial-mesenchymal transition. They lose the proteins that cells use to bind to each other and have other protein alterations that are characteristic of spreading cancer cells.
"Since ES cells can be grown in the laboratory where they keep the characteristics of the cells in the early embryo they can be studied in detail. By studying these ES cells we have already identified a novel component of this transition process. We expect the use of ES cells will lead to the identification of other unknown factors involved in cancer cell spread, hopefully leading to new avenues for cancer therapy."
Previously, it has been quite difficult to study this crucial transition in cancer cells as it only happened to a limited number of cells in a growing tumour. The team's discovery that it happens spontaneously in ES cells means that it can be studied more easily in the laboratory.
"Understanding how cancer cells start to spread is tremendously important for cancer research; tumours that do not spread are rarely, if ever, dangerous," said Dr Ward, who leads the stem cell research group in the School of Dentistry.
"It is the ability of tumours to invade into other tissues and spread around the body that makes them so dangerous. Finding out more about the mechanism that controls the spread of cancer cells will help us find new treatments that can prevent tumours spreading and make them essentially harmless."
The study, which was funded by the Association for International Cancer Research (AICR) and also involved the University's Immunology Group at the Paterson Institute for Cancer Research (PICR), used embryonic stem cells to investigate how the protein E-cadherin stopped cells from migrating during normal growth.
The team found that, as well as helping cells stick together, E-cadherin also blocked the action of another protein known to increase the mobility of cells. This important dual function of E-cadherin opens up the potential for new targets to prevent tumours from spreading.
Derek Napier, Chief Executive of AICR, said: "Dr Ward's work will open the door to a detailed dissection of the process that makes cancers spread around the body.
"Scientific research occasionally makes sudden leaps forward when a new way of investigating something is discovered. We predict that this will lead to a huge growth in our understanding of cancer spread and the development on several new approaches to stopping it."
University of Manchester
Normal cells, as well as early cancer cells, are called epithelial cells because they bind tightly to each other forming stable layers of tissue. However, as a tumour becomes more advanced, some of the cells change to become 'mesenchymal'.
Mesenchymal cells do not bind to each other, forming more disorganised tissues in which the cells can move around. Since this crucial change - known as the epithelial-mesenchymal transition, was first observed in the early embryo, Dr Ward theorised that embryonic stem cells might undergo a similar process.
Dr Ward, whose findings are published in the journal Molecular Biology of the Cell, said: "We have shown that ES cells spontaneously change in a manner that is remarkably similar to the epithelial-mesenchymal transition. They lose the proteins that cells use to bind to each other and have other protein alterations that are characteristic of spreading cancer cells.
"Since ES cells can be grown in the laboratory where they keep the characteristics of the cells in the early embryo they can be studied in detail. By studying these ES cells we have already identified a novel component of this transition process. We expect the use of ES cells will lead to the identification of other unknown factors involved in cancer cell spread, hopefully leading to new avenues for cancer therapy."
Previously, it has been quite difficult to study this crucial transition in cancer cells as it only happened to a limited number of cells in a growing tumour. The team's discovery that it happens spontaneously in ES cells means that it can be studied more easily in the laboratory.
"Understanding how cancer cells start to spread is tremendously important for cancer research; tumours that do not spread are rarely, if ever, dangerous," said Dr Ward, who leads the stem cell research group in the School of Dentistry.
"It is the ability of tumours to invade into other tissues and spread around the body that makes them so dangerous. Finding out more about the mechanism that controls the spread of cancer cells will help us find new treatments that can prevent tumours spreading and make them essentially harmless."
The study, which was funded by the Association for International Cancer Research (AICR) and also involved the University's Immunology Group at the Paterson Institute for Cancer Research (PICR), used embryonic stem cells to investigate how the protein E-cadherin stopped cells from migrating during normal growth.
The team found that, as well as helping cells stick together, E-cadherin also blocked the action of another protein known to increase the mobility of cells. This important dual function of E-cadherin opens up the potential for new targets to prevent tumours from spreading.
Derek Napier, Chief Executive of AICR, said: "Dr Ward's work will open the door to a detailed dissection of the process that makes cancers spread around the body.
"Scientific research occasionally makes sudden leaps forward when a new way of investigating something is discovered. We predict that this will lead to a huge growth in our understanding of cancer spread and the development on several new approaches to stopping it."
University of Manchester
Cancer Cells Current Events and Cancer Cells News RSSHodgkin lymphoma -- new characteristics discovered
Researchers are still discovering new characteristics of Hodgkin lymphoma, a common form of cancer of the lymphatic system. The malignant cells are derived from white blood cells (B cells), but have lost a considerable part of the B cell-specific gene expression pattern.
Bisphenol A linked to chemotherapy resistance
Exposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists.
What is the influence of tumor removal on the serum level of carbohydrate's antibody?
Cancer immune surveillance is considered to be important in the anti-tumor protection of the host. The growing tumor escapes the immune control under the immunosuppressive conditions.
Burnham Researchers Turn Cancer Friend into Cancer Foe
Burnham Institute for Medical Research today announced that scientists have created a peptide that binds to Bcl-2, a protein that protects cancer cells from programmed cell death, and converts it into a cancer cell killer.
Research shows Brazilian acai berry antioxidants absorbed by human body
A Brazilian palm berry sweeping the globe as a popular health food - though little research has been done on it - now may have its purported benefits better understood.
Nanoscopic screening process to speed drug discovery
Researchers at Wake Forest University are using nanotechnology to search for new cancer-fighting drugs through a process that could be up to 10,000 times faster than current methods.
Nanodiamond drug device could transform cancer treatment
A Northwestern University research team has developed a promising nanomaterial-based biomedical device that could be used to deliver chemotherapy drugs locally to sites where cancerous tumors have been surgically removed.
The Structure of the Mre11 Protein Bound to DNA
Repairing breaks in the two strands of the DNA double helix is critical for avoiding cancer. In humans and other organisms, a molecular machine called the MRN complex is responsible for finding and signaling double-strand breaks (DSBs), then launching the error-free method of DNA repair called homologous recombination.
When cells go bad
When a cell's chromosomes lose their ends, the cell usually kills itself to stem the genetic damage. But University of Utah biologists discovered how those cells can evade suicide and start down the path to cancer.
Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
In pre-clinical studies, vitamin C appears to substantially reduce the effectiveness of anticancer drugs, say researchers at Memorial Sloan-Kettering Cancer Center.
More Cancer Cells Current Events and Cancer Cells News Articles
 | Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development) (Cancer Drug Discovery and Development) Cancer chemotherapy can be traced back to the 1940 s and since then the world has witnessed the discovery and the important application of several new drugs. The successes of combination chemotherapy suggested that all cancers can be treated provided that the correct combination of drugs at the correct doses and correct intervals are established. However, with time, tumor cells develop mechanisms... |
 | The Society of Cells: Cancer and Control of Cell Proliferation by Pr Sonnenschein For more than 30 years, the majority of researchers has assumed quiescence to be the default state of all cells and so have provided cells in culture with 'growth factors' to stimulate them to proliferate. During this time, many putative growth factors have been identified and ever more complex mechanisms through which they could interact and stimulate cells have been proposed. However,... |
 | One Renegade Cell: The Quest For The Origin Of Cancer (Science Masters) by Robert A. Weinberg For everyone whose life has been touched by cancer, One Renegade Cell tells the story of the search for the ultimate causes of this dreaded disease. "One Renegade Cell…offers a breathtaking picture, both wonderful and frightening, of the fantastic intricacy of aberrant cellular functioning." -New York Times "Part primer, part history and part meditation. [One Renegade Cell] succeeds... |
 | Renal Cell Cancer: Diagnosis and Therapy Renal Cell Cancer: Diagnosis and Therapy covers a number of topics in the field of renal cell cancer ranging from diagnostics, cancer research, molecular biology, immunology and clinical management. It provides an overview of a significant amount of new information concerning epidemiology, molecular and immunologic characteristics and surgical therapy for patients with these tumors that has... |
 | Cancer Stem Cells: Novel Concepts and Prospects for Tumor Therapy Cancer stem cells werehave originally been identified in leukemia and later in several solid tumor types. They have very different properties from the bulk of the tumor, as they divide much more slowly and have very efficient drug- resistance mechanisms. Current treatments might largely spare cancer stem cells, thus leading to tumor recurrence and metastasis. The recent identification of growth... |
 | Cancer Stem Cells: Identification and Targets Because the concept and discoveries of cancer stem cells are relatively new, scientists and researchers need an introduction to this dynamic area. Cancer Stem Cells presents a consolidated account of the research done to date and recent progresses in the studies of cancer stem cells. Such a presentation facilitates a better understanding of and draws attention to stem cell and cancer biology -... |
 | Cell Motility in Cancer Invasion and Metastasis Cancer Morbidity and mortality result from invasive and metastatic spread. Currently, no therapies are aimed at the underlying mechanisms that enable this progression due to only nascent recognition of the distinct biology which occurs only during tumor dissemination. Recent advances have highlighted the central role of cell motility during the dynamic and transient process of tumor invasion and... |
 | Cancer Cell Culture: Methods and Protocols (Methods in Molecular Medicine) (Methods in Molecular Medicine) Expert researchers describe in detail their most productive and up-to-date methods for growing cancer cells in the laboratory. There are methods to characterize and authenticate cell lines, to isolate and develop specific types of cancer cells, and to develop new cell line models. Functional assays are provided to evaluate clonogenicity, cell proliferation, apoptosis, adhesion, migration,... |
 | Comprehensive Handbook of Childhood Cancer and Sickle Cell Disease: A Biopsychosocial Approach Over recent decades, tremendous advances in the prevention, medical treatment, and quality of life issues in children and adolescents surviving cancer have spawned a host of research on pediatric psychosocial oncology. This important volume fulfills the clear need for an up-to-date, comprehensive handbook for practitioners that delineates the most recent research in the field--the first of its... |
 | The Official Patient's Sourcebook on Renal Cell Cancer: A Revised and Updated Directory for the Internet Age by Icon Health Publications This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to renal cell cancer (also Adenocarcinoma of renal cells; Cancer kidney;... |
| © 2008 BrightSurf.com |